Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jazz Pharmaceuticals
Pharma
On heels of M&A deal, Jazz scores new FDA nod
The FDA approved Modeyso for patients 1 and older with H3 K27M-mutant diffuse midline glioma who have progressive disease following prior therapy.
Eric Sagonowsky
Aug 6, 2025 3:26pm
Jazz hits a sour note in 2 rebukes from UK marketing watchdog
Jul 11, 2025 10:51am
Chord change at Jazz as Renee Gala replaces Bruce Cozadd as CEO
Jul 10, 2025 11:06am
ASCO: Roche, Jazz lung cancer win leaves room for improvement
May 22, 2025 5:00pm
Jazz Pharma settles Xyrem antitrust claims for $145M
Apr 10, 2025 8:50am
Axsome's Sunosi scores in phase 3 ADHD trial
Mar 25, 2025 11:46am
